Greenberg Traurig, accused of malpractice in its representation of Jupiter-based biotechnology company Dyadic International Inc., asserts financial problems experienced by the company are the responsibility of its founder Mark Emalfarb as well as former officers at Dyadic and its Hong Kong-based subsidiary, Puridet Asia Ltd.
The Miami-based law firm made its assertions in a response to an amended lawsuit brought against the firm by Dyadic. The response, filed Aug. 22 by Gerald Richman of Richman Greer in West Palm Beach, says Emalfarb knew as early as 1998 when he bought an interest in Puridet that its management engaged in improper accounting and tax practices.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
